SENS
Senseonics Holdings, Inc.
SENS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SENS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
SENS's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SENS PE Valuation
SENS has no meaningful PE right now: it lost money over the past year.
SENS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SENS's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SENS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.27 | -$0.64 |
| Q2 2026 | -$2.20 | -$0.20 |
| Q1 2026 | -$1.97 | +$0.23 |
| Q4 2025 | -$1.66 | +$0.74 |
| Q3 2025 | -$1.63 | +$0.97 |
| Q2 2025 | -$2.00 | +$0.60 |
| Q1 2025 | -$2.20 | +$0.60 |
| Q4 2024 | -$2.40 | -$0.20 |
SENS is still losing money, but far less than before: $2.27 per share over the past year, against $32.20 at its worst in mid-2021.
SENS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.6M | +142% |
| Q2 2026 | $14.5M | +118% |
| Q1 2026 | $11.7M | +87% |
| Q4 2025 | $14.3M | +72% |
| Q3 2025 | $8.1M | +90% |
| Q2 2025 | $6.6M | +37% |
| Q1 2025 | $6.3M | +24% |
| Q4 2024 | $8.3M | +3.3% |
SENS's revenue has grown year over year for eight quarters in a row: $20M last quarter, up 142% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -163% | +79 points |
| Q2 2026 | -248% | -33 points |
| Q1 2026 | -272% | -56 points |
| Q4 2025 | -147% | +25 points |
| Q3 2025 | -242% | +294 points |
| Q2 2025 | -215% | +185 points |
| Q1 2025 | -216% | +146 points |
| Q4 2024 | -172% | +40 points |
SENS's operating margin was −163% last quarter, up 79 points from the same quarter a year ago, near the top of its range since 2019.
SENS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$33.2M | -$17.2M |
| Q2 2026 | -$30.4M | -$21M |
| Q1 2026 | -$32.1M | -$15.6M |
| Q4 2025 | -$18.4M | -$4.1M |
| Q3 2025 | -$16M | -$1.4M |
| Q2 2025 | -$9.4M | +$3.8M |
| Q1 2025 | -$16.5M | +$4.1M |
| Q4 2024 | -$14.3M | +$957K |
SENS has burned cash in almost every quarter: −$114M over the past year, against −$56M the year before.
SENS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +7.9M shares |
| 1 year | +46% | +20.8M shares |
| 3 years | +122% | +36.1M shares |
| 5 years | +497% | +54.7M shares |
SENS has 66M diluted shares, up 46% from a year ago.
SENS Net Leverage
SENS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SENS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 63.0 | Neutral |
SENS's weekly RSI is 59 (neutral) and its Stochastic is 63 (neutral).
SENS PE vs Healthcare Sector
SENS has no meaningful PE right now: it lost money over the past year.
SENS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.04 | 11% above |
| 20 week MA | $8.00 | 25% above |
| 50 week MA | $7.20 | 39% above |
| 100 week MA | $9.40 | 6.8% above |
| 200 week MA | $10.5 | 4.7% below |
SENS has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 4.7% below its 200-week average.
SENS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.1 | $18.2 | +0.4% |
| 2021 | $18.2 | $59.0 | +224% |
| 2022 | $59.0 | $20.4 | -65% |
| 2023 | $20.4 | $11.4 | -44% |
| 2024 | $11.4 | $11.8 | +3.9% |
| 2025 | $11.8 | $6.02 | -49% |
| 2026 YTD | $6.02 | $10.0 | +67% |
SENS's yearly returns have swung widely, from +224% in 2021 to −65% in 2022. It's up 67% so far in 2026.